Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918981 · ClinicalTrials.gov registry record · NA
Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02918981 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 50 participants.
The verdict
NCT02918981, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Using stable isotope methodology, investigators will determine the postabsorptive and postprandial muscle protein synthetic response in 60 female adults (Age 50-79, BMI: \<30 kg/m2) immediately after an acute bout of resistance exercise. Participants will be divided in to 5 groups of twelve women (n=12). Each group will receive a different protein beverage or placebo to consume following the resistance exercise training. Group 1 will consume a beverage consisting of whey protein; group 2 will consume whey protein supplemented with additional leucine; group 3 will consume whey protein supplemented with additional leucine and hydrolyzed whey peptides; group 4 will consume whey protein supplemented with additional leucine and citrulline; group 5 will just consume water. During the testing, blood and muscle samples will be collected.
Interventions
- BEHAVIORAL Resistance Exercise
- DIETARY_SUPPLEMENT 14 g Whey protein
- DIETARY_SUPPLEMENT 6.6 g Whey protein + 1.25 g leucine
- DIETARY_SUPPLEMENT 4 g Whey protein + 1.25 g leucine + 2.6 g Whey peptides
- DIETARY_SUPPLEMENT 6.6 g Whey protein + 1.25 g leucine + 0.8 g Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918981
The ClinicalTrials.gov registry entry for NCT02918981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Resistance Exercise is the first listed.
NCT02918981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918981 about?
NCT02918981 is a clinical study titled "Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women". Using stable isotope methodology, investigators will determine the postabsorptive and postprandial muscle protein synthetic response in 60 female adults (Age 50-79, BMI: \<30 kg/m2) immediately after an acute bout of resistance exercise. Participants will be divided in to 5 groups of twelve women (n...
What is the current status of trial NCT02918981?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-10. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT02918981?
The interventions under investigation include: Resistance Exercise (BEHAVIORAL), 14 g Whey protein (DIETARY_SUPPLEMENT), 6.6 g Whey protein + 1.25 g leucine (DIETARY_SUPPLEMENT), 4 g Whey protein + 1.25 g leucine + 2.6 g Whey peptides (DIETARY_SUPPLEMENT), 6.6 g Whey protein + 1.25 g leucine + 0.8 g Citrulline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02918981?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.